These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12741614)

  • 1. Physicochemical characterization and drug release studies of nilvadipine solid dispersions using water-insoluble polymer as a carrier.
    Hirasawa N; Ishise S; Miyata H; Danjo K
    Drug Dev Ind Pharm; 2003 Mar; 29(3):339-44. PubMed ID: 12741614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An attempt to stabilize nilvadipine solid dispersion by the use of ternary systems.
    Hirasawa N; Ishise S; Miyata H; Danjo K
    Drug Dev Ind Pharm; 2003 Oct; 29(9):997-1004. PubMed ID: 14606663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of drug-carrier interaction on the dissolution behavior of solid dispersion tablets.
    Srinarong P; Kouwen S; Visser MR; Hinrichs WL; Frijlink HW
    Pharm Dev Technol; 2010; 15(5):460-8. PubMed ID: 20735300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-polymer interaction and its significance on the physical stability of nifedipine amorphous dispersion in microparticles of an ammonio methacrylate copolymer and ethylcellulose binary blend.
    Huang J; Wigent RJ; Schwartz JB
    J Pharm Sci; 2008 Jan; 97(1):251-62. PubMed ID: 17724668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxypropyl cellulose stabilizes amorphous solid dispersions of the poorly water soluble drug felodipine.
    Sarode AL; Malekar SA; Cote C; Worthen DR
    Carbohydr Polym; 2014 Nov; 112():512-9. PubMed ID: 25129775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluate the ability of PVP to inhibit crystallization of amorphous solid dispersions by density functional theory and experimental verify.
    Wang B; Wang D; Zhao S; Huang X; Zhang J; Lv Y; Liu X; Lv G; Ma X
    Eur J Pharm Sci; 2017 Jan; 96():45-52. PubMed ID: 27568852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interplay of formulation and process methodology on the extent of nifedipine molecular dispersion in polymers.
    Huang J; Li Y; Wigent RJ; Malick WA; Sandhu HK; Singhal D; Shah NH
    Int J Pharm; 2011 Nov; 420(1):59-67. PubMed ID: 21871546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.
    Ghanavati R; Taheri A; Homayouni A
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier.
    Yin LF; Huang SJ; Zhu CL; Zhang SH; Zhang Q; Chen XJ; Liu QW
    Drug Dev Ind Pharm; 2012 Nov; 38(11):1371-80. PubMed ID: 22296267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and physicochemical characterizations of tanshinone IIA solid dispersion.
    Zhao X; Liu X; Gan L; Zhou C; Mo J
    Arch Pharm Res; 2011 Jun; 34(6):949-59. PubMed ID: 21725816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions.
    Sun M; Wu C; Fu Q; Di D; Kuang X; Wang C; He Z; Wang J; Sun J
    Int J Pharm; 2016 Apr; 503(1-2):238-46. PubMed ID: 26869398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
    Wlodarski K; Sawicki W; Haber K; Knapik J; Wojnarowska Z; Paluch M; Lepek P; Hawelek L; Tajber L
    Eur J Pharm Biopharm; 2015 Aug; 94():106-15. PubMed ID: 25998701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of nilvadipine solid dispersion to tablet formulation and manufacturing using crospovidone and methylcellulose as dispersion carriers.
    Hirasawa N; Ishise S; Miyata H; Danjo K
    Chem Pharm Bull (Tokyo); 2004 Feb; 52(2):244-7. PubMed ID: 14758011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions.
    Djuris J; Milovanovic S; Medarevic D; Dobricic V; Dapčević A; Ibric S
    Int J Pharm; 2019 Jan; 554():190-200. PubMed ID: 30414899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid state and dissolution rate characterization of co-ground mixtures of nifedipine and hydrophilic carriers.
    Friedrich H; Nada A; Bodmeier R
    Drug Dev Ind Pharm; 2005 Sep; 31(8):719-28. PubMed ID: 16221606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and solubility study of solid dispersions of flunarizine and polyvinylpyrrolidone.
    Marín MT; Margarit MV; Salcedo GE
    Farmaco; 2002 Sep; 57(9):723-7. PubMed ID: 12385522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congruent release of drug and polymer: A "sweet spot" in the dissolution of amorphous solid dispersions.
    Saboo S; Mugheirbi NA; Zemlyanov DY; Kestur US; Taylor LS
    J Control Release; 2019 Mar; 298():68-82. PubMed ID: 30731151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical characterization of solid dispersions of three antiepileptic drugs prepared by solvent evaporation method.
    Douroumis D; Bouropoulos N; Fahr A
    J Pharm Pharmacol; 2007 May; 59(5):645-53. PubMed ID: 17524229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced dissolution and bioavailability of grapefruit flavonoid Naringenin by solid dispersion utilizing fourth generation carrier.
    Khan AW; Kotta S; Ansari SH; Sharma RK; Ali J
    Drug Dev Ind Pharm; 2015 May; 41(5):772-9. PubMed ID: 24669978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
    Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.